Retatrutide, a experimental dual stimulator of the GLP-1 binding site and glucose-dependent secreted polypeptide (GIP) target, is showing promising outcomes in early patient trials . Ongoing https://listbell.com/story11265937/retatrutide-emerging-studies-and-potential-medical-applications